“…The power of elevated activity of PBGD to produce PpIX was clinically demonstrated for malignant gliomas (Stummer et al, 1998b); oral cavity cancer (Leunig et al, 2000a); colonic and gastrointestinal dysplasia (Stepp et al, 1998); peritoneal endometriosis (Hillemanns et al, 2000); laryngeal neoplasms (Leunig et al, 2000b); malignant lesions of the oesophagus (Hinnen et al, 1998); lower urinary tract tumours (Kriegmair et al, 1999); bladder cancer (Kriegmair et al, 1996); malignant mucosa in head and neck cancer (Betz et al, 1999); Barrett's oesophagus and adenocarcinoma (Stepp et al, 1998); basal and squamous cell carcinoma (Orenstein et al, 1995(Orenstein et al, , 1996(Orenstein et al, , 1997Malik et al, 1998) and coetaneous lymphoma (Orenstein et al, 2000).…”